RT Journal Article
SR Electronic
T1 Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP 1700214
DO 10.1183/13993003.00214-2017
A1 Claus F. Vogelmeier
A1 Gerard J. Criner
A1 Fernando J. Martinez
A1 Antonio Anzueto
A1 Peter J. Barnes
A1 Jean Bourbeau
A1 Bartolome R. Celli
A1 Rongchang Chen
A1 Marc Decramer
A1 Leonardo M. Fabbri
A1 Peter Frith
A1 David M. G. Halpin
A1 M. Victorina López Varela
A1 Masaharu Nishimura
A1 Nicolas Roche
A1 Roberto Rodriguez-Roisin
A1 Don D. Sin
A1 Dave Singh
A1 Robert Stockley
A1 Jørgen Vestbo
A1 Jadwiga A. Wedzicha
A1 Alvar Agusti
YR 2017
UL http://erj.ersjournals.com/content/early/2017/02/24/13993003.00214-2017.1.abstract
AB This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: 1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; 2) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; 3) the concept of deescalation of therapy is introduced in the treatment assessment scheme; 4) nonpharmacologic therapies are comprehensively presented and; 5) the importance of comorbid conditions in managing COPD is reviewed.